Common structural requirements for peroxisome proliferation by tetrazole and carboxylic acid-containing compounds

Annals of the New York Academy of Sciences

Volumn 804, Issue , 1996, Pages 387-402

  Eacho, Patrick I ^a   Foxworthy, Patricia S ^a   Lawrence, Jeffrey W ^a   Herron, David K ^a   Noonan, Daniel J ^b  

^a ELI LILLY AND COMPANY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 HYDROXY 3 PROPYL 4 [[4 (1H TETRAZOL 5 YLMETHYL)PHENOXY]METHYL]PHENYL]ETHANONE; 5,8,11,14 ICOSATETRAYNOIC ACID; CARBOXYLIC ACID; CLOFIBRATE; FATTY ACID; LEUKOTRIENE D4 RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PEROXISOME PROLIFERATOR; PIRINIXIC ACID; TETRAZOLE DERIVATIVE; TOMELUKAST;

ANIMAL CELL; ANIMAL EXPERIMENT; BINDING SITE; CHEMICAL STRUCTURE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG CONFORMATION; DRUG STRUCTURE; HYDROPHOBICITY; LIPID METABOLISM; METHYLATION; NONHUMAN; PEROXISOME; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALIA;

EID: 0030468112     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb18630.x     Document Type: Conference Paper

References (30)

1. REDDY, J. K. & N. D. LALWANI. 1983. Carcinogenesis by hepatic peroxisome proliferators: Evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit. Rev. Toxicol. : 1-58.
2. EACHO, P. I. & D. R. FELLER. 1991. Hepatic peroxisome proliferation induced by hypolipidemic drugs and other chemicals. In Antilipidemic Drugs: Medicinal, Chemical and Biochemical Aspects. D. K. WITIAK, H. A. I. NEWMAN & D. R. FELLER, Eds.: 375-426. Elsevier, Amsterdam.
3. EACHO, P. I., P. S. FOXWORTHY & D. K. HERRON. 1993. Tetrazole substituted acetophenone peroxisome proliferators: Structure-activity relationships and effects on hepatic lipid metabolism. In Peroxisomes: Biology and Importance in Toxicology and Medicine. G. G. GIBSON and B. G. LAKE, Eds: 343-372. Taylor and Francis Ltd. London.
4. LAKE, B. G., D. F. V. LEWIS, T. J. B. GRAY & J. A. BEAMAND. 1993. Structure-activity relationships for induction of peroxisomal enzyme activities in primary rat hepatocyte cultures. Toxic. In Vitro 7: 605-614.
5. KOZUKA, H., J. YAMADA, S. HORIE, T. WATANABE, T. SUGA & T. IKEDA. 1991. Characteristics of induction of peroxisomal fatty acid oxidation-related enzymes in rat liver by drugs: Relationships between structure and inducing activity. Biochem. Pharmacol. 41: 617-623.
6. MCGUIRE, E. J., J. A. LUCAS, R. H. GRAY & F. A. DE LA IGLESIA. 1991. Peroxisome induction potential and lipid-regulating activity in rats: Quantitative microscopy and chemical structure-activity relationships. Am. J. Pathol. 139: 217-229.
7. BERGE, R. K., K. H. AARSLAND, J. BREMER & N. AARSAETHER. 1989. Alkylthioacetic acid (3-thia fatty acids) - a new group of non-β-oxidizable, peroxisome-inducing fatty acid analogs. II. Dose-response studies on hepatic peroxisomal and mitochondrial changes and long chain fatty acid metabolizing enzymes in rats. Biochem. Pharmacol. 38: 3969-3979.
8. IKEDA, T., K. AIBA, K. FUKUDA & M. TANAKA. 1985. The induction of peroxisome proliferation in rat liver by perfluorinated fatty acids, metabolically inert derivatives of fatty acids. J. Biochem. 98: 475-482.
9. HERTZ, R., J. BAR-TANA, M. SUJATTA, J. PILL, H. SCHMIDT & H. D. FAHIMI. 1988. The induction of liver peroxisomal proliferation by beta, beta′-methyl-substituted hexadecanoic acid (MEDICA 16). Biochem. Pharmacol. 37: 3571-3577.
10. BREMER, J. & K. R. NORUM. 1982. Metabolism of very long-chain monounsaturated fatty acids (22:1) and the adaptation to their presence in the diet. J. Lipid Res. 23: 243-256.
11. ELCOMBE, C. R. & A. M. MITCHELL. 1986. Peroxisome proliferation due to di-(2-ethylhexyl) phthalate: Species differences and possible mechanisms. Environ. Hlth. Perspec. 70: 211-219.
12. LOCK, E. A., A. M. MITCHELL & C. R. ELCOMBE. 1989. Biochemical mechanisms of induction of hepatic peroxisome proliferation. Annu. Rev. Pharmacol. Toxicol. 29: 145-163.
13. SHARMA, R., B. G. LAKE & C. G. GIBSON. 1988. Co-induction of microsomal cytochrome P-452 and the peroxisomal fatty acid β-oxidation pathway in the rat by clofibrate and di-(2-ethylhexyl) phthalate. Biochem. Pharmacol. 37: 1203-1206.
14. BRONFMAN, M., L. AMIGO & M. N. MORALES. 1986. Activation of hypolipidaemic drugs to acyl-coenzyme A thioesters. Biochem. J. 239: 781-784.
15. FOXWORTHY, P. S. & P. I. EACHO. 1988. Inhibition of hepatic fatty acid oxidation at carnitine palmitoyltransferase I by the peroxisome proliferator 2-hydroxy-3-propyl-4-[6-(tetrazol-5-yl) hexyloxy] acetophenone. Biochem J. 252: 409-414.
16. LAZAROW, P. B. & C. DE DUVE. 1976. A fatty acyl-CoA oxidizing system in rat liver peroxisomes: Enhancement by clofibrate, a hypolipidemic drug. Proc. Natl. Acad. Sci. USA 73: 2042-2046.
17. ISSEMANN, I. & S. GREEN. 1990. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347: 645-650.
18. MUERHOFF, A. S., K. J. GRIFFIN & E. F. JOHNSON. 1992. The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid hydroxylase, by clofibric acid. J. Biol. Chem. 267: 19051-19053.
19. BESNARD, P., A. MALLORDY & H. CARLIER. 1993. Transcriptional induction of the fatty acid binding protein gene in mouse liver by bezafibrate. FEBS Lett. 327: 219-223.
20. TUGWOOD, J. D., I. ISSEMANN, R. G. ANDERSON, K. R. BUNDELL, W. L. MCPHEAT & S. GREEN. 1992. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 11: 433-439.
21. MARCUS, S. L., K. S. MIYATA, B. ZHANG, B., S. SUBRAMANI, R. A. RACHUBINSKI & J. P. CAPONE. 1993. Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferator-responsive elements of the rat hydratase/dehydrogenase and fatty acyl CoA oxidase genes but differentially induce expression. Proc. Natl. Acad. Sci. USA 90: 5723-5727.
22. GOTTLICHER, M., E. WIDMARK, Q. LI & J. A. GUSTAFSSON. 1992. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA 89: 4653-4657.
23. GOTTLICHER, M., A. DEMOZ, D. SVENSSON, P. TOLLET, R. K. BERGE & J. A. GUSTAFSSON. 1993. Structural and metabolic requirements for activators of the peroxisome proliferator-activated receptor. Biochem. Pharmacol. 46: 2177-2184.
24. KELLER, H., C. DREYER, J. MEDIN, A. MAHFOUDI, K. OZATO & W. WAHLI. 1993. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc. Natl. Acad. Sci. USA 90: 2160-2164.
25. MARSHALL, W. S., T. GOODSON, G. J. CULLINAN, D. SWANSON-BEAN, K. D. HAISCH, L. E. RINKEMA & J. H. FLEISCH. 1987. Leukotriene receptor antagonists. 1. Synthesis and structure-activity relationships of alkoxyacetophenone derivatives. J. Med. Chem. 30: 682-689.
26. EACHO, P. I., P. S. FOXWORTHY, W. D. JOHNSON, D. M. HOOVER & S. L. WHITE. 1986. Hepatic peroxisomal changes induced by a tetrazole-substituted alkoxyacetophenone in rats and comparison with other species. Toxicol. Appl. Pharmacol. 83: 430-437.
27. GROSSMAN, S. J., J. G. DELUCA, R. J. ZAMBONI, K. P. KEENAN, D. H. PATRICK, E. G. HEROLD, M. J. VAN ZWIETEN & A. G. ZACCHEI. 1992. Enantioselective induction of peroxisomal proliferation in CD-1 mice by leukotriene antagonists. Toxicol. Appl. Pharmacol. 116: 217-224.
28. 4 antagonist. Fund. Appl. Toxicol. 23: 298-303.
29. THORNBER, C. W. 1979. Isosterism and molecular modification in drug design. Chem. Soc. Rev. 8: 563-580.
30. EACHO, P. I., P. S. FOXWORTHY, R. D. DILLARD, G. A. WHITESITT, D. K. HERRON & W. S. MARCHALL. 1989. Induction of peroxisomal β-oxidation in the rat liver in vivo and in vitro by tetrazole-substituted acetophenones: Structure-activity relationships. Toxical. Appl. Pharmacol. 100: 177-184.